Novo Nordisk Shares Decline Amid Competitive Pressure
Novo Nordisk Shares Decline Amid Competitive Pressure
Novo Nordisk A/S Common Stock (NYSE:NVO) experienced a notable decline on Thursday. This movement follows a significant announcement from competitor Viking Therapeutics Inc. (NASDAQ:VKTX).
諾和諾德普通股（NYSE：NVO）在星期四經歷了顯着下跌。此舉是跟隨競爭對手Viking Therapeutics Inc.（NASDAQ：VKTX）的重要公告而動作的。
What To Know: Viking Therapeutics announced the company has advanced its obesity candidate VK2735 into late-stage trials. This advancement has intensified competition in the GLP-1 market, which is currently led by Novo Nordisk and Eli Lilly corp. (NYSE:LLY).
需要注意的是：Viking Therapeutics宣佈公司已將其肥胖症候選藥物VK2735推進了後期試驗階段。這一進展加劇了GLP-1市場的競爭，該市場目前由Novo Nordisk和Eli Lilly corp.（NYSE：LLY）主導。
Viking Therapeutics' report of promising results for its obesity drug, showing up to a 15% reduction in body weight over 13 weeks, has pressured Novo Nordisk. This development challenges Novo Nordisk's leading position in the obesity treatment market.
Viking Therapeutics報告其肥胖症藥物有希望的結果，顯示在13個星期內體重減輕高達15％，這給諾和諾德帶來了壓力。這一進展挑戰了諾和諾德在肥胖症治療市場中的領先地位。
What Else: The options market for Novo Nordisk has shown a predominantly bearish sentiment recently. Out of eight detected trades, 62% were bearish, including three put options totaling $155,555 and five call options amounting to $255,360.
其他方面：諾和諾德的期權市場最近顯示出明顯的看淡情緒。在檢測到的8筆交易中，有62％是看淡的，包括總計155,555美元的三隻看跌期權和總計255,360美元的五隻看漲期權。
Novo Nordisk's trading volume reached 1,568,565, with the stock nearing oversold conditions according to RSI indicators. The company's next earnings report is expected in 13 days.
諾和諾德的交易量達到了1,568,565，根據RSI指標，該股票接近超賣條件。公司的下一個收益報告預計在13天內發佈。
Analyst Opinions: Cantor Fitzgerald recently downgraded Novo Nordisk to 'Overweight' but maintained a price target of $160.
分析師意見：Cantor Fitzgerald最近將諾和諾德股票評級下調至“超重”，但維持160美元的目標價。
NVO Price Action: Novo Nordisk shares were down by 2.88% at $127.86 according to Benzinga Pro.
根據Benzinga Pro的數據，諾和諾德的股價下跌了2.88％，報127.86美元。
- Can Independent Bank Corp. Run Higher on Rising Earnings Estimates?
- 獨立銀行公司（Independent Bank Corp.）是否能在收益預期上升的推動下繼續上漲？
Photo via Shutterstock.
圖片來自shutterstock。
譯文內容由第三人軟體翻譯。